GLOBAL IN-VITRO FERTILIZATION MARKET FORECAST 2018-2026

  • You are here:
  • Home
  • Reports
  • GLOBAL IN-VITRO FERTILIZATION MARKET FORECAST 2018-2026

GLOBAL IN-VITRO FERTILIZATION MARKET FORECAST 2018-2026

Global In-vitro fertilization market is estimated to grow with approx.10.59% CAGR during the year 2018 – 2026. The base year considered for the study is 2017 and the forecast period is between 2018-2026. Global In-vitro fertilization market is primarily driven by the following factors: Increasing rate of infertility across the globe. Flexible government regulations for fertility tourism

GLOBAL IN-VITRO FERTILIZATION MARKET FORECAST 2018-2026

In-vitro Fertilization Market by Product (Reagents, Equipment) by Procedure (ICSI, PGD, FET/FER) by End-user (Fertility and Surgical Centers, Hospitals and Research Laboratories, Cryobanks) by Geography

Request free sample

The global in-vitro fertilization market is estimated to grow with approx.10.59% CAGR during the year 2018 – 2026. The base year considered for the study is 2017 and the forecast period is 2018-2026. Global In-vitro fertilization market is primarily driven by the following factors:

  • Increasing rate of infertility across the globe
  • Flexible government regulations for fertility tourism
  • Improved surrogacy laws
  • High success rates of advanced in-vitro fertilization treatments

In-Vitro Fertilization Market

To learn more about this report, request a free sample copy

The key factor responsible for the rising adoption of in-vitro fertilization techniques is the increasing rate of infertility across the globe. According to the World Health Organization (WHO), one in every six couple suffers from infertility related issues. Infertility is caused by various reasons such as physiological dysfunction, anatomical or genetic disorder, STDs (Sexually Transmitted Diseases), and endocrinological or immunological problems. Malaria, gonorrhoea, Chlamydia (Sexually transmitted infection) and other diseases may also cause infertility. Physiological causes that may cause infertility are tubal blockage, congenital malformation, abnormal ovulation, low quality and quantity of sperm and ejaculatory dysfunctions. World Health Organization estimates that the secondary infertility increases from 5% for the age 20 – 24 years to  62% by the age 45- 49.

Intracytoplasmic sperm injection (ICSI) is a procedure in which the sperm is directly injected into eggs that are obtained from in vitro fertilization (IVF). ICSI is advised when there is difficulty in achieving fertilization. ICSI is most commonly used procedures for people suffering from male infertility factors. These factors include: slow movement of the sperm or poor mortality, poor sperm quality, low sperm counts, sperm that lacks the ability to penetrate the egg or azoospermia. ICSI has been applied majorly to cure problems of severe male infertility in human patients who can neither be assisted by conventional IVF procedures nor be accepted for IVF.

High cost involved in in-vitro fertilization and country wise regulatory issues are the major factors hindering the in-vitro fertilization market. The high cost of IVF procedures is one of the significant factors restraining the market growth due to which the IVF treatment is still beyond the reach of a large number of infertile women. According to the American Pregnancy Association, IVF treatment cost in case of a woman aged below 35 is less, and it increases as the age of woman increases. The maximum age that is entertained by the majority of clinics around the globe is 44 years. The cost of IVF treatment is the highest in the US, and when coupled with egg donation it becomes very expensive even for the local residents. Due to variation in the costs of treatment and low cost of living, an increasing number of couples are availing the treatment from Panama, Mexico, India, and Thailand at an affordable cost. Total expenses also include diagnosis cost and the cost of the medicines, which together makes the IVF treatments very costly.

The global in-vitro fertilization market segments include products, procedures, and end user.

Products are segmented into:

  • Reagents
  • Equipments

Procedures are segmented into:

  • Intra-Cytoplasmic Sperm Injection
  • Pre-Implantation Genetic Diagnosis
  • Frozen Embryo Transfer/Replacement
  • Others

 

End –users are segmented into:

  • Fertility and Surgical Centers
  • Hospitals and Research Laboratories
  • Cryobanks

 

The report scope is widely categorized on the basis of its components which includes products and procedures. Moreover, the market revenue estimates and forecasts include only in-vitro fertilization techniques and exclude the conventional infertility treatments.

Geographically, the global In-vitro fertilization market has been segmented on the basis of four major regions, which include:

Europe dominated the global in-vitro fertilization market by capturing the largest market share during the forecast period. Europe IVF market is primarily driven by low fertility rate, government support for the adoption of in vitro fertilization, increasing healthcare expenditure and the high success rate of IVF methods. According to UN’s world fertility pattern 2015 report, the average fertility rate in Europe was 1.6 children per women in 2015 which is very much low as compared to the global average of 2.5 children per women in 2015. Such low fertility rate in Europe is the primary driver for the high adoption of in-vitro fertilization. Further, proactive government support for the adoption of IVF is also proving to be a major driver for the growth of the IVF market in Europe. On the other hand, the IVF technology is also gaining pace in the Asia Pacific region, as the infertility rates are spiralling there. Additionally, the rapidly rising geriatric population is a major concern for countries with below average birth rates such as Indonesia, Vietnam, Cambodia and the Philippines. Also, the rising trends towards delaying pregnancy has steadily increased in China and many other Asian countries, resulting in ageing of the eggs, making it less suitable for fertilization. This, in turn, has increased the need for IVF services in the APAC region.

The In-vitro fertilization market is segmented based on products (which are sub-divided into reagents and equipments), and also on the basis of procedures (which are sub-divided into intra-cytoplasmic sperm injection , pre-implantation genetic diagnosis, frozen embryo transfer/replacement and others).  End-users for this market include fertility and surgical centers, hospitals and research laboratories, and cryobanks.

The major market players in the global in-vitro fertilization market are:

  • Vitrolife
  • Cooper Surgical
  • Merck
  • Cook Medical
  • Ferring Pharmaceuticals
  • Others

Company Profiles covers analysis of important players

These companies are using organic and inorganic strategies for growth. For instance, in June 2016, Vetrolife acquired Octax, which develops and produces OCTAX Laser and Imaging Systems. The acquisition will strengthen the position of the former in the medical sector as well as broaden the product portfolio within the growth segments of IVF. In November 2016, Cooper Surgical acquired Smiths Medical – Wallace, a manufacturer of products such as micropipettes, needles, and catheters for assisted reproduction and IVF.

Key Findings of the global in-vitro fertilization market.

  • Increasing rate of infertility across the globe and improved surrogacy laws is fueling growth in the global in-vitro fertilization market.
  • Europe accounted for the largest revenue share in 2017
  • Intra Cytoplasmic Sperm Injection (ICSI) is dominating the market due to its growing adoption to cure problems like severe male infertility
  • Increasing government support
  • Product launch is the key strategy adopted by various market players of the global in-vitro fertilization market.
  • Fertility and surgical centers are the major end-user segments.
  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
    • RESEARCH METHODOLOGY
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • EUROPE DOMINATES THE GLOBAL IVF MARKET
      • ASIA PACIFIC AND MIDDLE-EAST MARKET TO SHOW GREAT PROMISE OVER THE FORECAST PERIOD
      • INSURANCE COVERAGE FOR IVF
      • GROWTH OF MEDICAL TOURISM
  1. MARKET DYNAMICS
    • MARKET DEFINITION
    • DRIVERS
      • INCREASING RATE OF INFERTILITY ACROSS THE GLOBE
      • FLEXIBLE GOVERNMENT REGULATIONS FOR FERTILITY TOURISM
      • IMPROVED SURROGACY LAWS
      • HIGH SUCCESS RATES OF ADVANCED IN-VITRO FERTILIZATION TREATMENTS
    • RESTRAINTS
      • HIGH COST
      • COUNTRY WISE REGULATORY ISSUES
    • OPPORTUNITIES
      • INCREASING DEMAND FOR LOW-COST PROCEDURES
      • IVF ATTRACTING INVESTMENTS FROM PRIVATE EQUITY INVESTORS
    • CHALLENGES
      • INFERTILITY CONSIDERED A SOCIAL TABOO AMONGST MEN
      • TRADITIONAL TREATMENTS USED WIDELY AS AN ALTERNATIVE TO IVF
        • DIET AND SUPPLEMENTS
        • ACUPUNCTURE
        • THERAPY
        • QIGONG
  1. MARKET BY PRODUCT AND PROCEDURES
    • BY PRODUCT
      • REAGENTS
      • EQUIPMENTS
    • BY PROCEDURE
      • INTRA CYTOPLASMIC SPERM INJECTION (ICSI)
      • PRE IMPLANTATION GENETIC DIAGNOSIS (PGD)
      • FROZEN EMBRYO TRANSFER/REPLACEMENT (FET/FER)
      • OTHERS
  1. MARKET BY END-USER
    • FERTILITY AND SURGICAL CENTERS
    • HOSPITALS AND RESEARCH LABORATORIES
    • CRYOBANKS
  2. KEY ANALYTICS
    • PORTER’S 5 FORCE MODEL
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTE PRODUCTS
      • BARGAINING POWER OF BUYERS
      • BARGAINING POWER OF SUPPLIERS
      • INTENSITY OF COMPETITIVE RIVALRY
    • VALUE CHAIN ANALYSIS
      • RAW MATERIAL PROCUREMENT
      • MANUFACTURING
      • SUPPLY LOGISTICS
      • DISTRIBUTION CHANNELS
      • END USERS
    • KEY BUYING CRITERIA
      • TREATMENT OPTIONS
      • QUALITY OF MEDICAL PROCEDURES
      • PRICE OF TREATMENTS
      • SHIFT TOWARDS MEDICAL TOURISM
      • REIMBURSEMENT
    • REGULATORY FRAMEWORK
    • INVESTMENT OUTLOOK
      • REGIONAL OUTLOOK
      • END-USER OUTLOOK
    • VENDOR LANDSCAPE
    • OPPORTUNITY MATRIX
  3. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • US
      • CANADA
    • EUROPE
      • UNITED KINGDOM
      • FRANCE
      • GERMANY
      • SPAIN
      • ITALY
      • REST OF EUROPE
    • ASIA-PACIFIC
      • CHINA
      • INDIA
      • JAPAN
      • SOUTH KOREA
      • AUSTRALIA
      • THAILAND
      • REST OF ASIA-PACIFIC
    • ROW
      • LATIN AMERICA
      • MIDDLE EAST & AFRICA
  1. COMPETITIVE LANDSCAPE
    • MARKET SHARE ANALYSIS
      • VITROLIFE
      • COOPER SURGICAL
      • MERCK
      • COOK MEDICAL
      • FERRING PHARMACEUTICALS
    • TOP WINNING STRATEGIES
    • COMPANY PROFILES
      • ANDROLOGY SOLUTIONS
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC ANALYSIS
      • AUXOGYN
        • OVERVIEW
        • PRODUCTS
        • STRATEGIC INITIATIVES
        • SCOT ANALYSIS
        • STRATEGIC ANALYSIS
      • COOK MEDICAL INC
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
        • SCOT ANALY
        • STRATEGIC ANALYSIS
      • COPPER SURGICAL INC
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
        • SCOT ANALYSIS
        • STRATEGIC ANALYSIS
      • ESCO MICRO PTE. LTD.
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
        • SCOT ANALYSIS
        • STRATEGIC ANALYSIS
      • FERRING PHARMACEUTICALS
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
        • SCOT ANALYSIS
        • STRATEGIC ANALYSIS
      • GENEA
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
        • SCOT ANALYSIS
        • STRATEGIC ANALYSIS
      • HALOTECH DNA
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC ANALYSIS
      • IRVINE SCIENTIFIC (SUBSIDIARY OF NIPPON MINING HOLDINGS)
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
        • SCOT ANALYSIS
        • STRATEGIC ANALYSIS
      • IVFTECH APS
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC ANALYSIS
      • MERCK SERONO
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
        • SCOT ANALYSIS
        • STRATEGIC ANALYSIS
      • OVASCIENCE
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
        • SCOT ANALYSIS
        • STRATEGIC ANALYSIS
      • THE BAKER COMPANY, INC.
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC ANALYSIS
      • THERMO FISHER SCIENTIFIC INC
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVE
        • SCOT ANALYSIS
        • STRATEGIC ANALYSIS
      • VITROLIFE AB
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
        • SCOT ANALYSIS
        • STRATEGIC ANALYSIS

LIST OF TABLES

TABLE 1 GLOBAL IN-VITRO FERTILIZATION MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 2 GLOBAL AVERAGE COST COMPARISON OF INFERTILITY TREATMENTS

TABLE 3 GLOBAL IVF MARKET BY PRODUCT AND PROCEDURES 2018-2026 ($ MILLION)

TABLE 4 GLOBAL IVF MARKET BY PRODUCTS 2018-2026 ($ MILLION)

TABLE 5 GLOBAL REAGENTS MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 6 GLOBAL EQUIPMENTS MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 7 GLOBAL IVF MARKET BY PROCEDURE 2018-2026 ($ MILLION)

TABLE 8 GLOBAL INTRACYTOPLASMIC SPERM INJECTION (ICSI) MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 9 GLOBAL PRE-IMPLANTATION GENETIC DIAGNOSIS (PGD) MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 10 GLOBAL FROZEN EMBRYO TRANSFER/REPLACEMENT (FET/FER) MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 11 GLOBAL OTHERS MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 12 GLOBAL IVF MARKET BY END-USER 2018-2026 ($ MILLION)

TABLE 13 GLOBAL FERTILITY AND SURGICAL CENTERS MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 14 GLOBAL HOSPITALS AND RESEARCH LABORATORIES MARKET BY GEOGRAPHY 2018-2026($ MILLION)

TABLE 15 GLOBAL CRYOBANKS MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 16 GLOBAL IVF MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 17 NORTH AMERICA IVF MARKET BY COUNTRY 2018-2026 ($ MILLION)

TABLE 18 EUROPE IVF MARKET BY COUNTRY 2018-2026 ($ MILLION)

TABLE 19 ASIA PACIFIC IVF MARKET BY COUNTRY 2018-2026 ($ MILLION)

TABLE 20 REST OF WORLD IVF MARKET 2018-2026 ($ MILLION)

 

LIST OF FIGURES

FIGURE 1 GLOBAL IN-VITRO FERTILIZATION MARKET BY PROCEDURE 2018-2026 ($ MILLION)

FIGURE 2 EUROPE IVF MARKET 2018-2026 ($ MILLION)

FIGURE 3 ASIA PACIFIC IVF MARKET 2018-2026 ($ MILLION)

FIGURE 4 MIDDLE EAST IVF MARKET 2018-2026 ($ MILLION)

FIGURE 5 EVOLUTION OF IVF MARKET

FIGURE 6 FALLING BIRTH RATE IN THE US (1960-2015)

FIGURE 7 GLOBAL REAGENTS MARKET 2018-2026 ($ MILLION)

FIGURE 8 GLOBAL EQUIPMENTS MARKET 2018-2026 ($ MILLION)

FIGURE 9 GLOBAL INTRACYTOPLASMIC SPERM INJECTION (ICSI) MARKET 2018-2026 ($ MILLION)

FIGURE 10 GLOBAL PRE-IMPLANTATION GENETIC DIAGNOSIS (PGD) MARKET 2018-2026 ($ MILLION)

FIGURE 11 GLOBAL FROZEN EMBRYO TRANSFER/REPLACEMENT (FET/FER) MARKET 2018-2026 ($ MILLION)

FIGURE 12 GLOBAL OTHERS MARKET 2018-2026 ($ MILLION)

FIGURE 13 GLOBAL FERTILITY AND SURGICAL CENTERS MARKET 2018-2026 ($ MILLION)

FIGURE 14 GLOBAL HOSPITALS AND RESEARCH LABORATORIES MARKET 2018-2026 ($ MILLION)

FIGURE 15 GLOBAL CRYOBANKS MARKET 2018-2026 ($ MILLION)

FIGURE 16 INVESTMENT PROPOSITION FOR GLOBAL IVF MARKET BY GEOGRAPHY – 2017

FIGURE 17 INVESTMENT PROPOSITION FOR GLOBAL IVF MARKET BY END-USER – 2017

FIGURE 18 CONTRACEPTIVE PREVALENCE AND UNMET NEED FOR FAMILY PLANNING AMONG MARRIED OR IN-UNION WOMEN AGED 15 TO 49 YEARS IN NORTH AMERICA IN (%) 2015

FIGURE 19 NUMBER OF IVF CYCLES PERFORMED IN THE US

FIGURE 20 UNITED STATES IVF MARKET 2018-2026 ($ MILLION)

FIGURE 21 FERTILITY RATE IN CANADA (NO. OF CHILD PER WOMEN)

FIGURE 22 CANADA IVF MARKET 2018-2026 ($ MILLION)

FIGURE 23 UNITED KINGDOM IVF MARKET 2018-2026 ($ MILLION)

FIGURE 24 FRANCE IVF MARKET 2018-2026 ($ MILLION)

FIGURE 25 GERMANY IVF MARKET 2018-2026($MILLION)

FIGURE 26 SPAIN IVF MARKET 2018-2026 ($ MILLION)

FIGURE 27 REST OF EUROPE IVF MARKET 2018-2026 ($ MILLION)

FIGURE 28 CHINA IVF MARKET 2018-2026 ($ MILLION)

FIGURE 29 INDIA IVF MARKET 2018-2026 ($ MILLION)

FIGURE 30 JAPAN IVF MARKET 2018-2026 ($ MILLION)

FIGURE 31 AUSTRALIA IVF MARKET 2018-2026 ($ MILLION)

FIGURE 32 REST OF ASIA-PACIFIC IVF MARKET 2018-2026 ($ MILLION)

FIGURE 33 FERTILITY RATE IN BRAZIL (CHILD PER WOMEN)

FIGURE 34 LATIN AMERICA IVF MARKET 2018-2026 ($ MILLION)

FIGURE 35 FERTILITY RATE BY COUNTRIES (CHILD PER WOMEN) 2015

FIGURE 36 MIDDLE EAST & AFRICA IVF MARKET 2018-2026 ($ MILLION)

FIGURE 37 GLOBAL IVF MARKET SHARE OF MAJOR COMPANIES – 2017

 

  1. MARKET BY PRODUCT AND PROCEDURES
    • BY PRODUCT
      • REAGENTS
      • EQUIPMENTS
    • BY PROCEDURE
      • INTRA CYTOPLASMIC SPERM INJECTION (ICSI)
      • PRE IMPLANTATION GENETIC DIAGNOSIS (PGD)
      • FROZEN EMBRYO TRANSFER/REPLACEMENT (FET/FER)
      • OTHERS
  1. MARKET BY END-USER
    • FERTILITY AND SURGICAL CENTERS
    • HOSPITALS AND RESEARCH LABORATORIES
    • CRYOBANKS
  2. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • US
      • CANADA
    • EUROPE
      • UNITED KINGDOM
      • FRANCE
      • GERMANY
      • SPAIN
      • ITALY
      • REST OF EUROPE
    • ASIA-PACIFIC
      • CHINA
      • INDIA
      • JAPAN
      • SOUTH KOREA
      • AUSTRALIA
      • THAILAND
      • REST OF ASIA-PACIFIC
    • ROW
      • LATIN AMERICA
      • MIDDLE EAST & AFRICA

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now